Indaptus Therapeutics Inc. – Underwriting Agreements Watch

from 8-K 37 pages Amended and Restated at the Market Offering Agreement

from 8-K 13 pages Placement Agent Agreement

from 8-K 12 pages Placement Agent Agreement

from S-3 ~1 page “Registration Statement” Shall Mean the Shelf Registration Statement on Form S-3 Registering $200,000,000 of Securities of the Company Filed on September 1, 2022, Including Exhibits and Financial Statements and Any Prospectus Supplement Relating to the Shares That Is Filed With the Commission Pursuant to Rule 424(b) and Deemed Part of Such Registration Statement Pursuant to Rule 430b, as Amended on Each Effective Date And, in the Event Any Post-Effective Amendment Thereto Becomes Effective, Shall Also Mean Such Registration Statement as So Amended. if You Are in Agreement With the Foregoing, Please Sign Where Indicated Below and Return a Signed Copy of This Amendment to US. Very Truly Yours, Indaptus Therapeutics, Inc. By: /S/ Nir Sassi Name: Nir Sassi Title: Chief Financial Officer Acknowledged and Agreed: H.C. Wainwright & Co., LLC By: /S/ Edward D. Silvera Name: Edward D. Silvera Title: Chief Operating Officer

from S-3 42 pages At the Market Offering Agreement June 1, 2022

from S-3 42 pages At the Market Offering Agreement June 1, 2022